ALNY vs PAYS · P/E 76, rev $1.29B vs P/E 43, rev $56.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Paysign Inc (PAYS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Paysign Inc (PAYS) is a software - infrastructure company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported PAYS revenue for 2026-06-30 was $56.3M. Net income was $12.2M. PAYS currently screens at market cap $407.6M and trailing P/E 42.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PAYS currently screens at market cap $407.6M and trailing P/E 42.9.
Not investment advice. Open the ALNY and PAYS stock pages for the full models.
Not investment advice.